NK1 receptor mediates cerebral cellular and extracellular morphological changes during the LPS-induced febrile responseShow others and affiliations
2024 (English)In: Brain Research, ISSN 0006-8993, E-ISSN 1872-6240, Vol. 1842, article id 149107Article in journal (Refereed) Published
Abstract [en]
Fever elicited by bacterial lypopolyssacharide (LPS) is mediated by pro-inflammatory cytokines, which activate central mediators and regulate the hypothalamic temperature setpoint. This response is often accompanied by morphological changes involving the extracellular matrix, neurons and glial cells, with significant health impacts. The NK1 receptor is involved in the febrile response induced by LPS but its effects over the extracellular matrix in the context of neuroinflammation remain unknown. The present work aims to clarify the extracellular changes associated with NK1 signaling in LPS-induced fever. Male Wistar rats were exposed to LPS intraperitoneally. Experimental groups were pre-treated intracerebroventricularly with the NK1 selective inhibitor SR140333B or saline. Histological changes involving the brain extracellular matrix were evaluated using hematoxylin and eosin, Mason's trichrome, picrosirius, alcian blue, periodic acid Schiff's stains. The expression of matrix metalloproteinase 9 (MMP9) was studied using confocal microscopy. Fever was accompanied by edema, perivascular lymphoplamacytic and neutrophylic infiltration, spongiosis and MMP9 overexpression. SR140333B significantly reduced LPS-induced fever (p < 0.0001), MMP9 overexpression (p < 0.01) and associated histological changes. These results contribute to characterize cerebral extracellular matrix changes associated with LPS-induced fever. Overall, the present work supports a role for NK1 receptor in these neuroinflammatory changes, involving MMP9 overexpression, edema and leukocytic infiltration.
Place, publisher, year, edition, pages
ELSEVIER , 2024. Vol. 1842, article id 149107
Keywords [en]
NK1 receptor; Neuroinflammation; Metalloproteinase; Bacterial lipopolysaccharide; Brain
National Category
Pharmacology and Toxicology
Identifiers
URN: urn:nbn:se:liu:diva-209310DOI: 10.1016/j.brainres.2024.149107ISI: 001347161500001PubMedID: 38977236OAI: oai:DiVA.org:liu-209310DiVA, id: diva2:1912225
Note
Funding Agencies|Fundacao de Amparo a Pesquisa e ao Desenvolvimento Cientifico e Tecnologico do Maranhao (FAPEMA) [00431/12]; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES/CAPES Sandwich Program) [007414/2014-05]; CAPES/PNPD; CAPES [001]; Research Center of the Portuguese Oncology Institute of Porto [PI86-CI-IPOP-66-2017]; FCT/MCTES (PIDDAC): LEPABE [UIDB/00511/2020, UIDP/00511/2020, LA/P/0045/2020]
2024-11-112024-11-112024-11-11